IP Library Granted Patent US 8,470,339
Granted Patent B2
US 8,470,339 · App. 12/513,802 · Granted Jun 25, 2013

Antigens for paratuberculosis diagnosis and vaccination

Inventors: Baptiste Leroy (Pipaix, BE); Ruddy Wattiez (Sirault, BE); Christiane A. J. Huygen (Brussels, BE); Virginie Roupie (Court-Saint-Etienne, BE); Marc Govaert (Brussels, BE); Isabelle Georis (Erpent, BE)
Assignees: Universite de Mons; Cerva-Coda; Institut Scientifique de Sante Publique
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,339
App. No.
12/513,802
Granted
Jun 25, 2013
Kind
B2
Abstract

The present invention discloses new antigens of Mycobacterium avium subsp. paratuberculosis , antigenic compositions comprising at least two of said antigens, as well as epitopes, antibodies or hypervariable fragments thereof and nucleotide sequences coding for them. The present invention also concerns their use in diagnosis and/or vaccination against Mycobacterium avium subsp. paratuberculosis , in mammals, and in particular in cattle, but also in sheep and caprines. The invention also concerns their potential application in diagnosis and/or vaccination against Crohn's disease in human.

Claims (20)

1. An isolated antigen of Mycobacterium avium subsp. paratuberculosis , said antigen comprising the amino acid sequence SEQ.ID.NO.1.

2. An antigenic composition of Mycobacterium avium subsp. paratuberculosis comprising the isolated antigen according to claim 1 and at least an isolated antigen comprising the amino acid sequence SEQ.ID.NO.2.

3. The antigenic composition according to claim 2 , further comprising an isolated antigen comprising the amino acid sequence SEQ.ID.NO.3.

4. The antigenic composition according to claim 2 , further comprising an isolated antigen comprising the amino acid sequence SEQ.ID.NO.4.

5. The antigenic composition according to claim 2 , further comprising an isolated antigen comprising the amino acid sequence SEQ.ID.NO.5.

6. The antigenic composition according to claim 2 , further comprising at least an isolated antigen comprising the amino acid sequence SEQ.ID.NO.6.

7. The antigenic composition according to claim 2 , further comprising an isolated antigen comprising the amino acid sequence SEQ.ID.NO.7.

8. An antigenic composition of Mycobacterium avium subsp. paratuberculosis comprising the isolated antigen according to claim 1 and at least one isolated antigen comprising the amino acid sequence SEQ.ID.NO.3 and an isolated antigen comprising the amino acid sequence SEQ.ID.NO.4.

9. An antigenic composition of Mycobacterium avium subsp. paratuberculosis comprising the isolated antigen according to claim 1 and an isolated antigen comprising the amino acid sequence SEQ.ID.NO.3.

10. An antigenic composition of Mycobacterium avium subsp. paratuberculosis comprising the isolated antigen according to claim 1 and an isolated antigen comprising the amino acid sequence SEQ.ID.NO.4.

11. An antigenic composition of Mycobacterium avium subsp. paratuberculosis comprising the isolated antigen according to claim 1 and at least one, at least two, at least three, at least four, at least five or at least six isolated antigen(s) comprising an amino acid sequence selected from the group consisting of SEQ.ID.NO.2, SEQ.ID.NO.3, SEQ.ID.NO.4, SEQ.ID.NO.5, SEQ.ID.NO.6 and SEQ.ID.NO.7.

12. The antigenic composition according to claim 11 , further comprising at least one isolated antigen comprising an amino acid sequence selected from the group consisting of SEQ.ID.NO.8 to SEQ.ID.NO.25.

13. An isolated antibody or hypervariable fragment thereof directed against the amino acid sequence SEQ.ID.NO.1 of the antigen according to claim 1 .

14. An isolated nucleotide sequence encoding the antigen according to claim 1 .

15. A pharmaceutical composition comprising an adequate pharmaceutical carrier and the antigenic composition according to claim 2 or an isolated nucleotide sequence encoding the antigen of claim 2 comprising the amino acid sequence of SEQ.ID.NO.1 or SEQ.ID.NO.2.

16. A diagnostic kit for the cellular diagnosis of Paratuberculosis in mammals, comprising the antigenic composition according to the claim 2 or an isolated nucleotide sequence encoding the antigen of claim 2 comprising the amino acid sequence of SEQ.ID.NO.1 or SEQ.ID.NO.2.

17. A pharmaceutical composition comprising an adequate pharmaceutical carrier and the antigen according to claim 1 or an isolated nucleotide sequence encoding the antigen according to claim 1 .

18. A diagnostic kit for the cellular diagnosis of Paratuberculosis in mammals, comprising the antigen according to the claim 1 or an isolated nucleotide sequence encoding the antigen according to claim 1 .

19. A diagnostic it for diagnosis of Paratuberculosis in mammals, the kit comprising the isolated antibody of claim 13 , or a hypervariable fragment thereof, and a reagent to detect binding of the antibody or hypervariable fragment to antigen.

20. A diagnostic kit for diagnosis of Paratuberculosis in mammals, comprising the isolated antibody, or a hypervariable fragment thereof, directed against the amino acid sequence SEQ.ID.NO.1 and an isolated antibody, or a hypervariable fragment thereof, directed against the amino acid sequence SEQ.ID.NO.2 of the antigen according to claim 2 .

Assignments (3)
MERGER Recorded Jun 29, 2011
From: UNIVERSITE DE MONS-HAINAUT
To: UNIVERSITE DE MONS
Reel/Frame 026525/0079 →
CORRECTIVE ASSIGNMENT TO CORRECT THE FIFTH INVENTOR'S LAST NAME PREVIOUSLY RECORDED ON REEL 023684 FRAME 0521. ASSIGNOR(S) HEREBY CONFIRMS THE FIFTH INVENTOR'S LAST NAME IS GOVAERTS, NOT GOVAERT.. Recorded Feb 17, 2011
From: BAPTISTE, LEROY; WATTIEZ, RUDDY; HUYGEN, CHRISTIANE A.J.; ROUPIE, VIRGINIE; GOVAERTS, MARC; GEORIS, ISABELLE
To: UNIVERSITE DE MONS HAINAUT; CERVA-CODA; INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE
Reel/Frame 025815/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2009
From: LEROY, BAPTISTE; WATTIEZ, RUDDY; HUYGEN, CHRISTIANE A.J.; ROUPIE, VIRGINIE; GOVAERT, MARC; GEORIS, ISABELLE
To: UNIVERSITE DE MONS HAINAUT; CERVA-CODA; INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE
Reel/Frame 023684/0521 →
Continuity (2)
Provisional Application 60857664 · Nov 6, 2006
Related Publication 20110200603A1 · Aug 18, 2011